Clinical Trial Update: Pilot Study: Lactoferrin for Prevention of Neonatal Sepsis [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated lactoferrin for prevention of neonatal sepsis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Lactoferrin (lactoferrin)

Snippet

Sponsor: Universidad Peruana Cayetano Heredia | Conditions: Sepsis | Phase 2 | Status: COMPLETED